Harvard Bioscience Inc (NASDAQ:HBIO)

2.57
Delayed Data
As of Sep 30
 -0.03 / -1.15%
Today’s Change
2.27
Today|||52-Week Range
8.23
-63.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues108.7M104.5M101.9M120.8M
 
 
 
 
 
Cost of Goods Sold58.2M54.6M52.9M55.1M
 
 
 
 
 
Depreciation And Amortization4.6M4.3M3.8M7.8M
 
 
 
 
 
 
Operating ExpensesGross Income45.9M45.7M45.2M57.8M
 
 
 
 
 
General Expenses46.8M46.7M45.3M56.8M
 
 
 
 
 
Other Operating Expenses-24.0K143.0K60.0K0.00
 
 
 
 
Research And Development6.4M5.4M5.6M11.0M
 
 
 
 
 
Total Operating Expenses109.6M105.7M102.0M119.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-925.0K-1.1M-101.0K984.0K
 
 
 
 
 
Extraordinary Charge-2.0M-772.0K-500.0K-3.4M
 
 
 
 
 
Interest Expense On Debt761.0K603.0K774.0K5.5M
 
 
 
 
 
Other Expenses58.0K-571.0K-713.0K-56.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.6M-3.1M-2.1M-8.0M
 
 
 
 
 
Income Taxes-15.4M-1.2M-1.2M-3.7M
 
 
 
 
 
Discontinued Operations0.000.000.00126.0K
 
 
Extraordinary Items0.000.000.001.3M
 
 
Net Income-19.0M-4.3M-865.0K-4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.6M34.2M34.8M36.5M
 
 
 
 
 
Shares To Calculate EPS Diluted33.6M34.2M34.8M36.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.57-$0.13-$0.02-$0.08
 
 
 
 
 
EPS Diluted-$0.57-$0.13-$0.02-$0.11